References
Anon (n.d.) Audiograms, gap detection thresholds, and frequency
difference limens in cannabinoid receptor 1 knockout mice - PubMed.
Available at: https://pubmed.ncbi.nlm.nih.gov/26427583/ [Accessed
December 16, 2024].B D, Lz F, Js F, S M, J H, Dk K, C W, C R, Y L, K
D, I S (2024a) Retrograde endocannabinoid signaling at inhibitory
synapses in vivo. Science (New York, NY) 383 Available at:
https://pubmed.ncbi.nlm.nih.gov/38422134/ [Accessed October 11,
2024].B G, K X, H M, K R, H X, Nd H, Y Z, J K, Y L, Y X, Y Z, Y Z, X
Z, Z F, Jf C, H H, W W, S W (2024b) CB1R dysfunction of inhibitory
synapses in the ACC drives chronic social isolation stress-induced
social impairments in male mice. Neuron 112 Available at:
https://pubmed.ncbi.nlm.nih.gov/37992714/ [Accessed October 11,
2024].Barti B, Dudok B, Kenesei K, Zöldi M, Miczán V, Balla GY, Zala
D, Tasso M, Sagheddu C, Kisfali M, Tóth B, Ledri M, Vizi ES, Melis M,
Barna L, Lenkei Z, Soltész I, Katona I (2024) Presynaptic nanoscale
components of retrograde synaptic signaling. Sci Adv
10:eado0077.Busquets-Garcia A, Bains J, Marsicano G (2018a) CB1 Receptor
Signaling in the Brain: Extracting Specificity from Ubiquity.
Neuropsychopharmacology 43:4–20.Busquets-Garcia A, Oliveira da Cruz JF,
Terral G, Pagano Zottola AC, Soria-Gómez E, Contini A, Martin H, Redon
B, Varilh M, Ioannidou C, Drago F, Massa F, Fioramonti X, Trifilieff P,
Ferreira G, Marsicano G (2018b) Hippocampal CB1 Receptors Control
Incidental Associations. Neuron 99:1247-1259.e7.Castillo PE, Younts TJ,
Chávez AE, Hashimotodani Y (2012) Endocannabinoid signaling and synaptic
function. Neuron 76:70–81.Clarke TL, Johnson RL, Simone JJ, Carlone RL
(2021) The Endocannabinoid System and Invertebrate Neurodevelopment and
Regeneration. Int J Mol Sci 22:2103.Domenici MR, Azad SC, Marsicano G,
Schierloh A, Wotjak CT, Dodt H-U, Zieglgänsberger W, Lutz B, Rammes G
(2006) Cannabinoid receptor type 1 located on presynaptic terminals of
principal neurons in the forebrain controls glutamatergic synaptic
transmission. J Neurosci 26:5794–5799.Erben L, Buonanno A (2019)
Detection and Quantification of Multiple RNA Sequences Using Emerging
Ultrasensitive Fluorescent In Situ Hybridization Techniques. Curr Protoc
Neurosci 87:e63.Fuerte-Hortigón A, Gonçalves J, Zeballos L, Masa R,
Gómez-Nieto R, López DE (2021) Distribution of the Cannabinoid Receptor
Type 1 in the Brain of the Genetically Audiogenic Seizure-Prone Hamster
GASH/Sal. Front Behav Neurosci 15:613798.Hu H, Gan J, Jonas P (2014)
Interneurons. Fast-spiking, parvalbumin+ GABAergic
interneurons: from cellular design to microcircuit function. Science
345:1255263.Huang ZJ, Paul A (2019) The diversity of GABAergic neurons
and neural communication elements. Nat Rev Neurosci 20:563–572.Hwang
J-H, Chan Y-C (2016) Expression of Dopamine Receptor 1A and Cannabinoid
Receptor 1 Genes in the Cochlea and Brain after Salicylate-Induced
Tinnitus. ORL J Otorhinolaryngol Relat Spec 78:268–275.Ji B, B C, S H,
Sph A, W O, Ar P, Mn W (2017) Effects of the cannabinoid CB1 agonist
ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs.
Hearing research 356 Available at:
https://pubmed.ncbi.nlm.nih.gov/29108871/ [Accessed October 11,
2024].Kendall DA, Yudowski GA (2016a) Cannabinoid Receptors in the
Central Nervous System: Their Signaling and Roles in Disease. Front Cell
Neurosci 10:294.Kendall DA, Yudowski GA (2016b) Cannabinoid Receptors in
the Central Nervous System: Their Signaling and Roles in Disease. Front
Cell Neurosci 10:294.Mailleux P, Vanderhaeghen JJ (1992) Distribution of
neuronal cannabinoid receptor in the adult rat brain: a comparative
receptor binding radioautography and in situ hybridization
histochemistry. Neuroscience 48:655–668.Marsicano G, Goodenough S,
Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutiérrez
SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schütz G,
Zieglgänsberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid
receptors and on-demand defense against excitotoxicity. Science
302:84–88.Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio
MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B
(2002) The endogenous cannabinoid system controls extinction of aversive
memories. Nature 418:530–534.Middleton JW, Kiritani T, Pedersen C,
Turner JG, Shepherd GMG, Tzounopoulos T (2011) Mice with behavioral
evidence of tinnitus exhibit dorsal cochlear nucleus hyperactivity
because of decreased GABAergic inhibition. Proc Natl Acad Sci U S A
108:7601–7606.Pf S, Y Z (2016) Cannabinoids, cannabinoid receptors and
tinnitus. Hearing research 332 Available at:
https://pubmed.ncbi.nlm.nih.gov/26433054/ [Accessed October 11,
2024].S C, T R, Kn F, Da L, Ra S (2022) Cell type specific cannabinoid
CB1 receptor distribution across the human and non-human primate cortex.
Scientific reports 12 Available at:
https://pubmed.ncbi.nlm.nih.gov/35688916/ [Accessed October 11,
2024].Stachowicz K (2023) Deciphering the mechanisms of reciprocal
regulation or interdependence at the cannabinoid CB1 receptors and
cyclooxygenase-2 level: Effects on mood, cognitive implications, and
synaptic signaling. Neurosci Biobehav Rev 155:105439.Steindel F, Lerner
R, Häring M, Ruehle S, Marsicano G, Lutz B, Monory K (2013) Neuron-type
specific cannabinoid-mediated G protein signalling in mouse hippocampus.
J Neurochem 124:795–807.Tao R, Li C, Jaffe AE, Shin JH, Deep-Soboslay
A, Yamin R, Weinberger DR, Hyde TM, Kleinman JE (2020) Cannabinoid
receptor CNR1 expression and DNA methylation in human prefrontal cortex,
hippocampus and caudate in brain development and schizophrenia. Transl
Psychiatry 10:158.Tzounopoulos T, Kraus N (2009) Learning to encode
timing: mechanisms of plasticity in the auditory brainstem. Neuron
62:463–469.Tzounopoulos T, Rubio ME, Keen JE, Trussell LO (2007)
Coactivation of pre- and postsynaptic signaling mechanisms determines
cell-specific spike-timing-dependent plasticity. Neuron 54:291–301.West
MJ (1999) Stereological methods for estimating the total number of
neurons and synapses: issues of precision and bias. Trends Neurosci
22:51–61.X L, X L, G Z, F W, L W (2020) Sexual dimorphic distribution
of cannabinoid 1 receptor mRNA in adult C57BL/6J mice. The Journal of
comparative neurology 528 Available at:
https://pubmed.ncbi.nlm.nih.gov/31997354/ [Accessed October 11,
2024].Y Z, Me R, T T (2009) Distinct functional and anatomical
architecture of the endocannabinoid system in the auditory brainstem.
Journal of neurophysiology 101 Available at:
https://pubmed.ncbi.nlm.nih.gov/19279154/ [Accessed October 11,
2024].Y Z, P R, Pf S (2015) Cannabinoid CB1 Receptor Agonists Do Not
Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in Rats.
Frontiers in neurology 6 Available at:
https://pubmed.ncbi.nlm.nih.gov/25852639/ [Accessed October 11,
2024].Y Z, Pf S (2019) Cannabinoid drugs: will they relieve or
exacerbate tinnitus? Current opinion in neurology 32 Available at:
https://pubmed.ncbi.nlm.nih.gov/30507635/ [Accessed October 11,
2024].Zhang C, Yan C, Ren M, Li A, Quan T, Gong H, Yuan J (2017) A
platform for stereological quantitative analysis of the brain-wide
distribution of type-specific neurons. Sci Rep 7:14334.Zhao Y, Rubio M,
Tzounopoulos T (2011) Mechanisms underlying input-specific expression of
endocannabinoid-mediated synaptic plasticity in the dorsal cochlear
nucleus. Hear Res 279:67–73.Zheng Y, Baek J-H, Smith PF, Darlington CL
(2007) Cannabinoid receptor down-regulation in the ventral cochlear
nucleus in a salicylate model of tinnitus. Hear Res 228:105–111.Zheng
Y, Reid P, Smith PF (2015) Cannabinoid CB1 Receptor Agonists Do Not
Decrease, but may Increase Acoustic Trauma-Induced Tinnitus in Rats.
Front Neurol 6:60.Zugaib J, Leão RM (2018) Enhancement of
Endocannabinoid-dependent Depolarization-induced Suppression of
Excitation in Glycinergic Neurons by Prolonged Exposure to High Doses of
Salicylate. Neuroscience 376:72–79.Figure LegendsFigure 1.
Distribution analysis of CB1Rs across various auditory nuclei.
(a) Immunostaining of CB1Rs in different auditory nuclei from
Cnr1flox/flox mice. The expression of CB1R proteins in
different auditory nuclei was demonstrated by fluorescence signals. CN, cochlear nucleus; SOC, superior olivary complex; LL, lateral
lemniscus; IC, inferior colliculus; MGB, medial geniculate body; AC,
auditory cortex. CN (n=10), SOC (n=7), LL (n=5), IC (n=8), AC (n=3), and
MGB (n=3). The scale-bar for all the micrographs is 100 μm.(b)(c) The number of CB1R-expressing neurons and the
average fluorescence intensities of CB1R proteins were quantified across
different auditory nuclei. The number of CB1R-expressing
neurons in distinct nuclei was manually counted using the unbiased
stereological method, and the average fluorescence intensity
(IntDen/Area) was analyzed for each nucleus.
Figure 2. Expression patterns of CB1Rs in subregions of central
auditory nuclei.
(a) Immunostaining of CB1Rs in subregions of auditory nuclei from
Cnr1flox/flox mice. The auditory nuclei of the CN,
SOC, and IC, along with their anatomical subregions, are shown in
detail. DCN, dorsal cochlear nucleus; AVCN, anterior ventral cochlear
nucleus; PVCN, posterior ventral cochlear nucleus; MSO, medial superior
olive; LSO, lateral superior olive; MNTB, medial nucleus of the
tapezoid body; ECIC, external cortex inferior colliculus; DCIC, dorsal
cortex inferior colliculus; CNIC, central nucleus inferior colliculus.
Numbers of mice used for analysis were: CN (n=10), SOC (n=7), LL (n=5),
IC (n=8), AC (n=3), and MGB (n=3). (b) Number of CB1Rs
expressing neurons. The number of CB1R-expressing neurons in subregions
was manually counted using the unbiased stereological method (For CN, F
(2, 28) = 59.40; DCN vs. PVCN, P=0.0018; DCN vs. AVCN,P<0.0001; PVCN vs. AVCN, P<0.0001. For
SOC, F (2, 36) = 80.65; MNTB vs. LSO, P= 0.0101; MNTB
vs. MSO, P<0.0001; LSO vs. MSO, P<0.0001.
For IC, F (2, 24) = 180.9; ECIC vs. CIC, P<0.0001; ECIC
vs. DCIC, P<0.0001; CIC vs. DCIC,P<0.0001). (c) Average fluorescence intensity of CB1R
proteins. The average fluorescence signal intensity was analyzed for
each subregion of the CN, SOC, and IC. (For CN, F (2, 27) = 26.53; DCN
vs. PVCN, P=0.0146; DCN vs. AVCN, P=0.0007; PVCN vs. AVCN,P<0.0001.For SOC, F (2, 18) = 2.559; MNTB vs. LSO,P= 0.1049; MNTB vs. MSO, P=0.2317; LSO vs. MSO,P<0.8893, For IC, F (2, 21) = 3.7; ECIC vs. CIC,P=16.94; ECIC vs. DCIC, P=15.76; CIC vs. DCIC,P=1.185).The data are presented as means ± standard error of the
mean (SEM). *p < 0.05, **p < 0.01,
****p < 0.0001.
Figure 3. CB1R knockout decreases the distribution of
CB1R+ PV-neurons.
(a) Double staining of PV and CB1Rs. The immunoreactivity for PV is
shown in red, while CB1Rs are shown in green. Co-localization of the two
markers in the CN and SOC regions is depicted in yellow (merged). The
number of mice used for the double-staining analysis was:
non-cKO: non-cKO (n=5) and Cnr1-cKO (n=5). (b) Comparison of PV
and CB1Rs expression. The number of CB1R+ neurons in
the CN and SOC was manually counted for each subregion, and the results
were compared between PV-Cre;Cnr1flox/flox and control
groups.
Similarly, the analysis of PV+ neurons was
performed. The average fluorescence intensity of PV was also quantified
for each subregion of the CN and SOC. The data are presented as means ±
standard error of the mean (SEM) (For the average fluorescence intensity
of PV, the interaction between non-cKO and Cnr1-cKO was significant: F
(5, 62) = 8.066; main effect of Cnr1-cKO: F (1, 62) = 18.45). For total
numbers of CB1R+ neurons, the interaction between
non-cKO and Cnr1-cKO: F (5, 61) = 50.83; main effect of Cnr1-cKO: F (1,
61) = 569.1. DCN, P<0.0001; PVCN, P=0.0155; AVCN,P<0.0001; MNTB, P<0.0001; MSO,P<0.0001; LSO, P<0.0001). *p< 0.05, **p < 0.01, ****p <
0.0001. (c) Co-localization analysis of PV and CB1Rs in the CN and SOC. The ratios of PV+ neurons expressing CB1Rs were
calculated and compared with those lacking CB1Rs.